CENTRAL WISCONSIN(WAOW)— A study by the ‘American Journal of Psychiatry’ claims CBD may help reduce opioid addiction cravings and anxiety.
The opioid epidemic continues to impact families in the badger state, and those struggling with the health crisis may be looking for any alternative.
In the first three months of 2019, Wisconsin had more than 400 suspected opioid overdoses according to the Wisconsin Department of Health Services.
The study looked at the impact of giving CBD, or cannabidiol, to people struggling with opioid use disorder.
It showed promise in reducing cravings and anxiety associated with people trying to stop using the powerful drug.
The study used the only FDA approved CBD prescription in its trials, Epiodiolex.
Epidiolex is currently approved for treatment of seizures associated with Dravent and Lennox-Gastaut syndromme (LGS).
The FDA approved drug is different from the products being marketed throughout central Wisconsin.
CBD products found in various shops, aren’t regulated at the same level as Epiodiolex.
“There’s a lot misconceptions about CBD containing products that are out there. For some that are available at health food stores, video stores, or vape shops. Those aren’t the same products that were used in this study,” said Melissa Moore, Prevention Specialist at Marathon County Health Department.
Right now, there are a number of different medical assisted treatment options for opioid addiction.
But the more options available for community members dealing with the addiction, the better chance for success.
“There’s a lot more research that needs to be done. But when we look at, how do we support recovery? Really giving people options, is really an effective way of getting them on that long term path,” said Moore.
This is only the first step in making CBD an available option for those dealing with opioid addiction.
A timeline is unknown as to when we may see CBD widely considered for help in treatment.